in clinical applications ranging from hematuria investigation to postsurgical follow-up, CT -- especially MDCT with multiplanar reconstruction -- has earned practitioners' respect for its ability to depict the entire urinary tract anatomy and quickly trace the source of problems.
Dear CT Insider,
The use of CT has become pervasive in urology, replacing radiographic procedures such as intravenous or retrograde pyelography with increasing frequency. The modality is no panacea; doctors at the recent American Association of Urology Meeting in San Francisco reported that cytoscopy is often still needed to nail down the diagnosis or confirm cancer recurrence.
But in clinical applications ranging from hematuria investigation to postsurgical follow-up, CT -- especially MDCT with multiplanar reconstruction -- has earned practitioners' respect for its ability to depict the entire urinary tract anatomy and quickly trace the source of problems. You'll find more about CT in urology in this issue's Insider Exclusive, published for our CT Insider subscribers first.
Also at the recent AUA meeting, a urologist from Sweden reported that CT/SPECT more than doubled the sensitivity of CT alone for presurgical staging for patients with bladder cancer.
In today's CT Digital Community, a new report warns that CT lung cancer screening could shorten the very lives it hopes to save. In another, doctors in Hawaii have found they could skip CTA in more than half of their pulmonary embolism cases by using a fast, relatively inexpensive D-Dimer test first.
Before you skip the CTA, however, you'll want to read about new studies showing that CTA data can be repurposed to assess the presence of myocardial infarction in patients who were scanned for other reasons.
Finally, we look forward to seeing you at Stanford Radiology's 6th Annual International Symposium on Multidetector-Row CT, beginning June 23 in San Francisco. If you find you cannot attend this premier MDCT conference, be sure to watch for our reports in the weeks to come.
